Comparing the current results to its competitors, Asensus Surgical Inc reported Revenue increase in the 2 quarter 2024 by 53.72 % year on year, while most of its competitors have experienced contraction in revenues by -2.42 %, achieved in the same quarter.
Asensus Surgical Inc , despite income growth by most of its competitors recorded a net loss, despite income increase by most of its competitors of 1.12 %
June 24, 2024
In a significant stride towards revolutionizing surgical procedures, Asensus Surgical, Inc. has announced a remarkable collaboration with the prestigious St. Marianna University School of Medicine Yokohama City Seibu Hospital in Japan. This ground-breaking agreement involves the deployment of Asensus Surgical s cutting-edge Senhance Surgical System, aimed at transforming the landscape of urology and gastroenterology/general surgery within the hospital. As the medical device company seeks to digitize the surgeon-patient interface, this collaboration signifies a significant step forward in the evolution of surgical technology and patient care.Redefining Surgical Precision and Efficiency:The Senhance Surgical S...
February 27, 2024
In an era of advancing medical technologies, Asensus Surgical, Inc. (NYSE American: ASXC) is leading the way in digitizing the surgeon-patient interface. The company recently achieved a significant milestone, completing over 1,000 successful cases at three renowned hospitals globally. Utilizing the innovative Senhance Surgical System, these hospitals include Klaipeda University Hospital in Lithuania, Presidential Clinic Astana in Kazakhstan, and Evangelisches Krankenhaus Wesel GmbH in Germany. This accomplishment not only highlights the growing adoption of robotic surgical systems but also affirms Asensus Surgical s commitment to revolutionizing the surgical landscape.Transforming Surgeon-Patient Dynamics:Th...
December 20, 2023
Asensus Announces Sale of Senhance Robotic System in Romania Timisoara, Romania - Asensus Surgical Inc, a leading medical technology company, has recently made an exciting announcement regarding the sale of their Senhance Robotic System to a pediatric hospital in Timisoara, Romania. This development marks a significant milestone for both Asensus Surgical Inc and the medical community in Romania. The Senhance Robotic System is an innovative surgical platform that combines the precision of robotics with the skill of human surgeons. It is designed to enhance the capabilities of surgeons, enabling them to perform minimally invasive procedures with enhanced dexterity and control. This state-of-the-art tec...
Intuitive Surgical Incs business model focuses on delivering robotic surgical systems, particularly the da Vinci Surgical System, which facilitates minimally invasive surgeries. Revenue is generated through system sales, instruments, accessories, and services, including training and maintenance for healthcare providers.
Fuse Medical Inc operates as a medical technology company that provides products and services to hospitals, surgical centers, and other healthcare facilities. Their business model involves offering a range of specialized surgical and orthopedic products, along with innovative solutions for inventory management and logistics. They strive to deliver high-quality medical supplies while emphasizing efficient distribution processes and cost-effective pricing strategies.
Edwards Lifesciences Corporations business model focuses on the development and commercialization of advanced medical technologies that enhance the diagnosis and treatment of heart disease, emphasizing innovative heart valves and critical care monitoring solutions. The company serves a diverse customer base, including hospitals and direct-to-patient markets, with a strong commitment to improving patient outcomes and quality of life.
Encision Inc is a medical device company that designs, develops, manufactures, and markets surgical products utilizing its patented active electrode monitoring technology for precision in minimally invasive surgeries, thereby providing increased patient safety and reduced overall healthcare costs. Their business model centers around creating and selling innovative surgical devices that incorporate their unique technology to improve surgical outcomes and enhance safety in the medical field.
Sources:
Asensus Surgical Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Asensus Surgical Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
